4613347729
Ahmed, M., Puckett, S., and Lyles, D.S. (2010). Susceptibility of breast cancer cells to an oncolytic matrix (M) protein mutant of vesicular stomatitis virus. Cancer Gene Ther. 17, 883-892.
Bloom, M.B., Perry-Lalley, D., Robbins, P.F., Li, Y., El-Gamil, M., Rosenberg, S.A., and Yang, J.C. (1997). Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the BI6 melanoma. The Journal of Experimental Medicine 185, 453-460.
Brutkiewicz, R.R., Bennink, J.R., Yewdell, J.W., and Bendelac, A. (1995). TAP-independent, beta 2-microglobulin-dependent surface expression of functional mouse CD 1.1. The Journal of Experimental Medicine 182, 1913-1919.
Calabi, F., and Bradbury, A. (1991). The CDI system. Tissue Antigens 37, 1-9.
Chang, G., Xu, S., Watanabe, M., Jayakar, H.R., Whitt, M.A., and Gingrich, J.R. (2010). Enhanced oncolytic activity of vesicular stomatitis virus encoding SV5-F protein against prostatę cancer. J. Uroi. 183, 1611-1618.
Charan, S., and Zinkemagel, R.M. (1986). Antibody mediated suppression of secondary IgM response in nudę mice against vesicular stomatitis virus. The Journal of Immunology 136, 3057-3061.
Desforges, M., Charron, J., Berard, S., Beausoleil, S., Stojdl, D.F., Despars, G., Laverdiere, B., Bell, J.C., Talbot, P.J., Stanners, C.P., and Poliąuin, L. (2001). DifTerent host-cell shutoff strategies related to the matrix protein lead to persistance of vesicular stomatitis virus mutants on fibroblast cells. Virus Res. 76, 87-102.
Diaz, R.M, Galivo, F., Kottke, T., Wongthida, P., Qiao, J., Thompson, J, Valdes, M., Barber, G., and Vile, R.G. (2007). Oncolytic Immunovirotherapy for Melanoma Using Vesicular Stomatitis Virus. Cancer Res. 67, 2840-2848.
Femandez, M., Porosnicu, M., Markovic, D., and Barber, G.N. (2002). Genetically Engineered Vesicular Stomatitis Virus in Gene Therapy: Application for Treatment of Malignant Disease. J. Virol. 76, 895-904.
Francoeur, M.A., Poliąuin, L., and Stanners, C.P. (1987). The Isolation of Interferon-Inducing Mutants of Vesicular Stomatitis Virus with Altered Viral P Function for the Inhibition of Total Protein Synthesis. Yirology 160, 236-245.
122
Wyszukiwarka
Podobne podstrony:
Ahmed, M., and Lyles, D.S. (1998). Effect of Vesicular Stomatitis Virus Matrix Protein on Transcript
References Ahmed, M., and Lyles, D.S. (1998). Effect of Vesicular Stomatitis Virus matrix protein on
McCreedy, and Lyles, D.S. (1989). Distribution of M protein and nucleocapsid protein of vesicular st
Flood, E.A., McKenzie, M.O., and Lyles, D.S. (2000). Role of M Protein aggregation m defective assem
Kelly, E.J., Nace, R., Barber, G.N., and Russell, S.J. (2010). Attenuation of Vesicular Stomatitis V
AIM AND SCOPE The aim of the conference is to provide an opportunity to share Information and facili
Blejwas - American Polonia and Września Another aspect of American Polonia role as an intermediary b
1972 Nations Unieś — Recueil des Traites 317 and tax-free importation of pedagogie materiał can
200 Marek Lubicz • Simulation Modelling of Breast Cancer Pathways, •
DSC04764 to interview 50 people, and for the sake of convenience you decide to interview both the hu
52270596412303729725q042322 n Simple five step plan for just about everyone and everything The numbe
skanuj0005 Assets and liabilities / • Any piece of property, • A debt owned to the ownership som
Mailbox Arts and Crafts For All Seasons3 As tali drcws to an a-d. expfc»n to yor Stvrientg haw dirr
Kopecky, S.A., and Lyles, D.S. (2003b). Contrastmg effects of matnx protein on apoptosis m HeLa and
więcej podobnych podstron